Trial Profile
Clinical efficacy of therapy with T-705 in patients with severe fever with thrombocytopenia syndrome
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Severe fever with thrombocytopenia syndrome
- Focus Therapeutic Use
- 02 May 2018 New trial record